Literature DB >> 2965682

Effect of neonatal injection with antibodies to Leishmania mexicana on its growth in adult infected mice.

R M Gorczynski1.   

Abstract

Mice inoculated with monoclonal antibodies (MAb) directed to Leishmania mexicana antigens were not protected from growth of a subsequent challenge infection; this was the case even when those antibodies were capable of inhibiting parasite growth in vitro. However F(ab')2 fragments of one antibody (1E1) were protective in vivo. When neonatal mice were injected with MAb and subsequently infected as adults, the animals were more susceptible to parasite growth than uninjected controls. This increased susceptibility could be adoptively transferred with Lyt-1+ cells. Separate groups of animals were immunized with different MAb to L. mexicana, and parasite growth in these animals was studied. In no case was parasite growth altered, though these mice did produce specific antibodies directed against the immunizing MAb (anti-idiotypic antibodies). When neonatal mice were injected with these latter reagents, they were found to be more resistant to challenge infection than control animals. This resistance was associated with an enhanced ability of spleen cells from these mice to produce, on stimulation with parasite antigens in vitro, a factor rendering normal macrophages cytocidal for L. mexicana.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965682      PMCID: PMC259837          DOI: 10.1128/iai.56.5.1376-1381.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  T-lymphocytes recognise Leishmania glycoconjugates.

Authors:  G F Mitchell; E Handman
Journal:  Parasitol Today       Date:  1985-08

2.  Protection of adult BALB/c mice against MOPC 315 myeloma by neonatal administration of monoclonal anti-idiotypic antibody to MOPC 315 IgA.

Authors:  R Gorczynski; R Baumal; M Boulanger; A Marks
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

3.  Immunization with Leishmania-specific T cell not B cell lines or hybridomas can modulate the response of susceptible mice infected with viable parasites.

Authors:  R M Gorczynski
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

4.  Identification of an infective stage of Leishmania promastigotes.

Authors:  D L Sacks; P V Perkins
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

5.  Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone.

Authors:  H C Ertl; R W Finberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

6.  Vaccination against the intracellular bacterium Listeria monocytogenes with a clonotypic antiserum.

Authors:  S H Kaufmann; K Eichmann; I Müller; L J Wrazel
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

7.  An anti-idiotype vaccine against experimental schistosomiasis.

Authors:  J M Grzych; M Capron; P H Lambert; C Dissous; S Torres; A Capron
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

8.  Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.

Authors:  J G Howard; S Nicklin; C Hale; F Y Liew
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

9.  Macrophage activation to kill Leishmania tropica: defective intracellular killing of amastigotes by macrophages elicited with sterile inflammatory agents.

Authors:  D L Hoover; C A Nacy
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

10.  Prophylactic treatment of BALB/c mice with cyclosporine A and its analog B-5-49 enhances resistance to Leishmania major.

Authors:  N C Behforouz; C D Wenger; B A Mathison
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.